Partnering

INSIGHTS ON CLINICAL TRIAL PARTNERING

What Controlled Immune Challenges Reveal Before Patient Studies Begin
Controlled immune challenges can reveal target engagement and pharmacology before efficacy is measurable, supporting earlier and more informed development decisions.
Paperless Online Remote Source Document Verification
Learn how Clinical Trial Organizations, Monitoring Teams and Clinical Sites can benefit from the way Judi transforms rSDV from a logistical hurdle into a strategic asset.
Creating Operational Efficiency And Competitive Edge
Site networks offer a strategic approach to oncology clinical trials by accelerating study startup and expanding access to diverse patient populations.
Scaling Outsourced Clinical Trial Services
Scaling outsourced clinical services increases operational pressure. Here’s where strain appears, how structure absorbs volume, and what sponsors should evaluate as programs expand.

Rescuing A Global Program For NDA Success
8/12/2025

Explore the collaboration that enabled FDA approval of a novel chronic-condition therapy, rescued a high-risk program, and demonstrated a unified “one-team” approach by reworking the sponsor's SAP.
Mergers And Acquisitions: How Institutional Knowledge Protecting Value
5/27/2026

M&A transitions can either preserve momentum or create costly setbacks. Learn how protecting institutional knowledge helps sponsors reduce risk, maintain continuity, and accelerate development.
Investigator Perspectives On What Matters In Obesity And GLP-1 Studies
7/22/2026

Retention, body composition, maintenance therapy, amylin combinations, and behavioral support are reshaping obesity trials. Learn how sponsors can reduce dropout risk and strengthen clinical data.
Targeted Protein Degraders: Transforming Oral Therapeutics
8/11/2025

CDMOs play a critical role in TPD development by offering specialized infrastructure and analytical capabilities to support the transition from preclinical research to clinical supply and commercialization.
Building A Scalable Oncology Engine In A Dynamic Market
6/3/2026

Learn how a top-10 global pharmaceutical company partnered with Medable to rapidly scale the number of oncology trials it could concurrently conduct.

What Our Portal Does For Sites, Sponsors, And Patients

Clinical trial portals should reduce friction—not add it. Streamlined tools empower sites, support patients, and give sponsors visibility without micromanagement or unnecessary complexity.
Helping To Bring Hematologic Oncology Therapies To Cancer Patients

Our mission is grounded in urgency and purpose: to shorten the time it takes for innovative blood cancer treatments to reach the patients and families who cannot afford to wait.
EU Clinical Trial Compliance: De-Risking CTR & CTIS

This essential guide walks through mastering the complex landscape of clinical trial regulations, providing a clear, practical breakdown of regulatory timelines, legal obligations, and more.
Early-Phase Oncology Research Expertise

Our priority is guiding promising therapies to proof-of-concept with precision and urgency, because every day saved in development matters profoundly to patients living with cancer.
Dual Sourcing: Mitigating Risk In Your Supply Chain

Dual sourcing should be implemented to reduce risk and ensure an uninterrupted supply of critical, life-saving therapies. Recent FDA draft guidelines recommend risk management plans to prevent drug product shortages.